I find this very hard to believe. I know first hand that even with small projects when Teva is involved they insist on taking every molecule or procedure and test them in-house before moving to the next step. And it's not that Teva doesn't have the ability or knowledge to do MALDI-MS, ESI-MS, HPLC, NMR and such to characterize enoxaparin (although not to the higher quality Momenta can).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.